Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 68 results.
User Information
Export Records
  1. 1.   Innate Immune Stimulation Using 3D Wireframe DNA Origami
  2. Du, Rebecca R; Cedrone,Edward; Romanov, Anna; Falkovich, Reuven; Dobrovolskaia,Marina; Bathe, Mark
  3. ACS Nano. 2022, Dec 02;
  1. 2.   Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
  2. Conlon, Kevin; Watson, Dionysios C; Waldmann, Thomas A; Valentin,Antonio; Bergamaschi,Cristina; Felber,Barbara; Peer, Cody J; Figg, William D; Potter, E Lake; Roederer, Mario; McNeel, Douglas G; Thompson, John A; Gupta, Sumati; Leidner, Rom; Wang-Gillam, Andrea; Parikh, Nehal S; Long, Debby; Kurtulus, Sema; Ho Lee, Lang; Chowdhury, Niladri Roy; Bender, Florent; Pavlakis,George
  3. Journal for immunotherapy of cancer. 2021, Nov; 9(11):
  1. 3.   Inhibition of Caspase-1 with Tetracycline Ameliorates Acute Lung Injury
  2. Peukert, Konrad; Fox, Mario; Schulz, Susanne; Feuerborn, Caroline; Frede, Stilla; Putensen, Christian; Wrigge, Hermann; Kummerer, Beate Mareike; David, Sascha; Seeliger, Benjamin; Welte, Tobias; Latz, Eicke; Klinman,Dennis; Wilhelm, Christoph; Steinhagen, Folkert; Bode, Christian
  3. American Journal of Respiratory and Critical Care Medicine. 2021, Jul 1; 204(1): 53-63.
  1. 4.   SMAC Mimetic/IAP Inhibitor Birinapant Enhances Radiosensitivity of Glioblastoma Multiforme
  2. Cerna, David; Lim, Bora; Adelabu, Yusuf; Yoo, Stephen; Carter, Donna; Fahim, Ahmed; Mitsuuchi, Yasuhiro; Teicher, Beverly A.; Bernhard, Eric; Coleman, C. Norman; Takebe, Naoko; Ahmed, Mansoor M.
  3. Radiation Research. 2021, Jun; 195(6): 549-560.
  1. 5.   The mechanism of full activation of tumor suppressor PTEN at the phosphoinositide-enriched membrane
  2. Jang,Hyunbum; Smith, Iris Nira; Eng, Charis; Nussinov,Ruth
  3. iScience. 2021, May 21; 24(5):
  1. 6.   The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation
  2. Sartorius, Kurt; An, Ping; Winkler,Cheryl; Chuturgoon, Anil; Li, Xiaodong; Makarova, Julia; Kramvis, Anna
  3. Frontiers in immunology. 2021, APR 29; 12
  1. 7.   Visualizing the Selectivity and Dynamics of Interferon Signaling In Vivo
  2. Stifter, Sebastian A.; Bhattacharyya, Nayan; Sawyer, Andrew J.; Cootes, Taylor A.; Stambas, John; Doyle, Sean E.; Feigenbaum, Lionel; Paul, William E.; Britton, Warwick J.; Sher, Alan; Feng, Carl G.
  3. Cell reports. 2019, Dec 10; 29(11): 3539-3550.e4.
  1. 8.   The RNA exosome nuclease complex regulates human embryonic stem cell differentiation
  2. Belair,Cedric; Sim,Soyeong; Kim, Kun-Yong; Tanaka, Yoshiaki; Park, In-Hyun; Wolin,Sandra
  3. The Journal of cell biology. 2019, AUG; 218(8): 2564-2582.
  1. 9.   Allostery in Its Many Disguises: From Theory to Applications
  2. Wodak, Shoshana J.; Paci, Emanuele; Dokholyan, Nikolay; Berezovsky, Igor N.; Horovitz, Amnon; Li, Jing; Hilser, Vincent J.; Behar, Ivet; Karanicolas, John; Stock, Gerhard; Hamm, Peter; Stote, Roland H.; Eberhardt, Jerome; Chebaro, Yassmine; Dejaegere, Annick; Cecchini, Marco; Changeux, Jean-Pierre; Bolhuis, Peter G.; Vreede, Jocelyne; Faccioli, Pietro; Orioli, Simone; Ravasio, Riccardo; Yen, Le; Brito, Carolina; Wyart, Matthieu; Gkeka, Paraskevi; Rivalta, Ivan; Palermo, Giulia; Mccammon, J. Andrew; Panecka-Hofman, Joanna; Wade, Rebecca C.; Di Pizio, Antonella; Niv, Masha Y.; Nussinov,Ruth; Tsai,Chung-Jung; Jang,Hyunbum; Padhorny, Dzmitry; Kozakov, Dima; Mcleish, Tom
  3. Structure (London, England : 1993). 2019, Apr 2; 27(4): 566-578.
  1. 10.   Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer
  2. Singh, Krishna B.; Ji,Xinhua; Singh, Shivendra V.
  3. MOLECULAR CANCER THERAPEUTICS. 2018, Oct; 17(10): 2079-2090.
  1. 11.   Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery
  2. Gregg, Kelsey A.; Harberts, Erin; Gardner, Francesca M.; Pelletier, Mark R.; Cayatte, Corinne; Yu, Li; McCarthy, Michael P.; Marshall, Jason; Ernst, Robert K.
  3. MBIO. 2017, May-Jun; 8(3):
  1. 12.   Nanotechnology-Based Cancer Therapeutics-Promise and Challenge-Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer
  2. Farrell, D.; Ptak, K.; Panaro, N. J.; Grodzinski, P.
  3. Pharmaceutical Research. 2011, Feb; 28(2): 273-278.
  1. 13.   Counteraction of HLA-C-Mediated Immune Control of HIV-1 by Nef
  2. Specht, A.; Telenti, A.; Martinez, R.; Fellay, J.; Bailes, E.; Evans, D. T.; Carrington, M.; Hahn, B. H.; Goldstein, D. B.; Kirchhoff, F.
  3. Journal of Virology. 2010, Jul; 84(14): 7300-7311.
  1. 14.   JS-K has potent anti-angiogenic activity in vitro and inhibits tumour angiogenesis in a multiple myeloma model in vivo
  2. Kiziltepe, T.; Anderson, K. C.; Kutok, J. L.; Jia, L.; Boucher, K. M.; Saavedra, J. E.; Keefer, L. K.; Shami, P. J.
  3. Journal of Pharmacy and Pharmacology. 2010, Jan; 62(1): 145-151.
  1. 15.   Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cells
  2. Liu, J.; Malavya, S.; Wang, X. Q.; Saavedra, J. E.; Keefer, L. K.; Tokar, E.; Qu, W.; Waalkes, M. P.; Shami, P. J.
  3. Genomics. 2009 94(1): 32-38.
  1. 16.   How do transcription factors select specific binding sites in the genome?
  2. Pan, Y. P.; Tsai, C. J.; Ma, B. Y.; Nussinov, R.
  3. Nature Structural & Molecular Biology. 2009 16(11): 1118-1120.
  1. 17.   JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)
  2. Shami, P. J.; Maciag, A. E.; Eddington, J. K.; Udupi, V.; Kosak, K. M.; Saavedra, J. E.; Keefer, L. K.
  3. Leukemia Research. 2009 33(11): 1525-1529.
  1. 18.   Ankyrin Repeat-Rich Membrane Spanning/Kidins220 Protein Regulates Dendritic Branching and Spine Stability In Vivo
  2. Wu, S. H.; Arevalo, J. C.; Sarti, F.; Tessarollo, L.; Gan, W. B.; Chao, M. V.
  3. Developmental Neurobiology. 2009 69(9): 547-557.
  1. 19.   Structural Basis of Focal Adhesion Localization of LIM-only Adaptor PINCH by Integrin-linked Kinase
  2. Yang, Y. W.; Wang, X. X.; Hawkins, C. A.; Chen, K.; Vaynberg, J.; Mao, X.; Tu, Y. Z.; Zuo, X. B.; Wang, J. B.; Wang, Y. X.; Wu, C. Y.; Tjandra, N.; Qin, J.
  3. Journal of Biological Chemistry. 2009 284(9): 5836-5844.
  1. 20.   Dietary flavonoids and colorectal adenoma recurrence in the polyp prevention trial
  2. Bobe, G.; Sansbury, L. B.; Albert, P. S.; Cross, A. J.; Kahle, L.; Ashby, J.; Slattery, M. L.; Caan, B.; Paskett, E.; Iber, F.; Kikendall, J. W.; Lance, P.; Daston, C.; Marshall, J. R.; Schatzkin, A.; Lanza, E.
  3. Cancer Epidemiology Biomarkers & Prevention. 2008 17(6): 1344-1353.
  1. 21.   Essentiality of ribosomal and transcription antitermination proteins analyzed by systematic gene replacement in Escherichia coli
  2. Bubunenko, M.; Baker, T.; Court, D. L.
  3. Journal of Bacteriology. 2007, Apr; 189(7): 2844-2853.
  1. 22.   Interferon: Cellular executioner or white knight?
  2. Maher, S. G.; Romero-Weaver, A. L.; Scarzello, A. J.; Gamero, A. M.
  3. Current Medicinal Chemistry. 2007 14(12): 1279-1289.
  1. 23.   JS-K, a nitric oxide prodrug, induces cytochrome c release and caspase activation in HL-60 myeloid leukemia cells
  2. Udupi, V.; Yu, M.; Malaviya, S.; Saavedra, J. E.; Shami, P. J.
  3. Leukemia Research. 2006, Oct; 30(10): 1279-1283.
  1. 24.   In vivo restoration of physiological levels of truncated TrkB.T1 receptor rescues neuronal cell death in a trisomic mouse model
  2. Dorsey, S. G.; Renn, C. L.; Carim-Todd, L.; Barrick, C. A.; Bambrick, L.; Krueger, B. K.; Ward, C. W.; Tessarollo, L.
  3. Neuron. 2006, Jul; 51(1): 21-28.
  1. 25.   Natural products from marine invertebrates and microbes as modulators of antitumor targets
  2. Newman, D. J.; Cragg, G. M.
  3. Current Drug Targets. 2006, MAR; 7(3): 279-304.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel